627 related articles for article (PubMed ID: 18353491)
1. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile.
Bishara J; Peled N; Pitlik S; Samra Z
J Hosp Infect; 2008 Apr; 68(4):308-14. PubMed ID: 18353491
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
3. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
4. [Six years evaluation of Clostridium difficile associated diarrhea].
Ercis S; Ergin A; Hasçelik G
Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901
[TBL] [Abstract][Full Text] [Related]
5. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea.
Raveh D; Rabinowitz B; Breuer GS; Rudensky B; Yinnon AM
Int J Antimicrob Agents; 2006 Sep; 28(3):231-7. PubMed ID: 16908119
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
[TBL] [Abstract][Full Text] [Related]
9. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation.
Vesta KS; Wells PG; Gentry CA; Stipek WJ
Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan.
Hsu MS; Wang JT; Huang WK; Liu YC; Chang SC
J Microbiol Immunol Infect; 2006 Jun; 39(3):242-8. PubMed ID: 16783456
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital.
Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ
J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443
[TBL] [Abstract][Full Text] [Related]
12. ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].
Sednaoui P; el Mantih B; Cauwell M
Pathol Biol (Paris); 1999 May; 47(5):415-21. PubMed ID: 10418011
[TBL] [Abstract][Full Text] [Related]
13. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].
Fernandez Canigia L; Nazar J; Arce M; Dadamio J; Smayevsky J; Bianchini H
Rev Argent Microbiol; 2001; 33(2):101-7. PubMed ID: 11494752
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.
Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A
J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection in patients with ileal pouch-anal anastomosis.
Shen BO; Jiang ZD; Fazio VW; Remzi FH; Rodriguez L; Bennett AE; Lopez R; Queener E; Dupont HL
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):782-8. PubMed ID: 18467184
[TBL] [Abstract][Full Text] [Related]
17. [Clostridium difficile strains not producing Toxin A, but producing Toxin B [toxA(-)tox B(+)]--etiologic agent of antibiotic associated diarrhoea (AAD) in Poland].
Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2002; 54(1):45-53. PubMed ID: 12185683
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease.
Miendje Deyi VY; Vandenberg O; Mascart G; Gning S; Retore P; Douat N; Dediste A
Clin Lab; 2008; 54(1-2):9-13. PubMed ID: 18510038
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
[TBL] [Abstract][Full Text] [Related]
20. Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea.
Peled N; Pitlik S; Samra Z; Kazakov A; Bloch Y; Bishara J
Infect Control Hosp Epidemiol; 2007 Apr; 28(4):377-81. PubMed ID: 17385141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
